Maternal serum levels of prokineticin-1 related to pregnancy complications and metformin use in women with polycystic ovary syndrome: a post hoc analysis of two prospective, randomised, placebo-controlled trials

OBJECTIVE: Serum prokineticin-1 (s-PROK1) in the second and third trimester of pregnancy is positively correlated to preeclampsia, intrauterine growth restriction (IUGR) and preterm delivery. Women with polycystic ovary syndrome (PCOS) are prone to these adverse pregnancy outcomes. However, the cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Ujvari, Dorina, Trouva, Anastasia, Hirschberg, Angelica Lindén, Vanky, Eszter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Obstetrics and Gynaecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668301/
https://www.ncbi.nlm.nih.gov/pubmed/37989369
http://dx.doi.org/10.1136/bmjopen-2023-073619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668301/
https://www.ncbi.nlm.nih.gov/pubmed/37989369
http://dx.doi.org/10.1136/bmjopen-2023-073619

Ejemplares similares